共 50 条
- [32] Integrating novel therapies into the management of moderate-to-severe ulcerative colitis: challenges and opportunities [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (02): : 110 - 112
- [38] Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 (10): : 1158 - 1169
- [40] Peripheral Blood DNA Methylation Signatures and Response to Tofacitinib in Moderate-to-severe Ulcerative Colitis [J]. JOURNAL OF CROHNS & COLITIS, 2023, 18 (08): : 1179 - 1189